Neela Therapeutics, Inc.

New Filing
CIK: 0002090797·Other Health Care·DELAWARE·Filed: Nov 24, 2025
Total Offering

$13,510,000

Amount Sold

$12,010,000

Investors

17

First Sale

Nov 14, 2025

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)

Related Persons

NameRole
PJ Anand
Executive Officer, Director
Norbert Riedel
Director
Richard Upton
Director
David Donabedian
Director
Cameron Durrant
Director
Edgar D. Jannotta Jr.
Director
Stephen Oesterle
Director

Company

Neela Therapeutics, Inc.

96 ROBBS HILL ROAD

LUNENBURG, MA, 01462

781-929-6094

SEC Filing

0002090797-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Neela Therapeutics, Inc. Form D Filing — $13,510,000 | FilingFlow